Immunic Therapeutics
Immunic Therapeutics is a Healthcare & Life Sciences startup based in New York, the United States, most recent round Series C+, 3 tracked investors.
About Immunic Therapeutics
Immunic Therapeutics is a startup founded in 2012 based in New York, the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Immunic Therapeutics is a clinical-stage biotechnology company developing orally administered small-molecule therapies for chronic inflammatory, autoimmune and neurologic diseases, with programs targeting multiple sclerosis, celiac disease and other immune-mediated conditions.
Explore Immunic Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.